Holen Sie sich die Stockscreener-App
117.36
1.26%
1.46
Handel nachbörslich:
117.42
0.06
+0.05%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$115.90
Offen:
$115.575
24-Stunden-Volumen:
4.82M
Relative Volume:
1.07
Marktkapitalisierung:
$202.64B
Einnahmen:
$41.22B
Nettoeinkommen (Verlust:
$5.77B
KGV:
39.92
EPS:
2.94
Netto-Cashflow:
$6.49B
1W Leistung:
+0.48%
1M Leistung:
-1.70%
6M Leistung:
+12.75%
1J Leistung:
+17.89%
1-Tages-Spanne:
$115.51
$117.94
1-Wochen-Bereich:
$114.43
$117.94
52-Wochen-Spanne:
$98.95
$121.64
Abbott Laboratories Stock (ABT) Company Profile
Firmenname
Abbott Laboratories
Sektor
Branche
Telefon
(224) 667-6100
Adresse
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Vergleichen Sie ABT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-08 | Eingeleitet | Oppenheimer | Outperform |
| 2024-09-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-07-30 | Herabstufung | Edward Jones | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-07-21 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | Bestätigt | Barclays | Overweight |
| 2023-04-20 | Bestätigt | Bernstein | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Raymond James | Outperform |
| 2023-04-20 | Bestätigt | UBS | Buy |
| 2023-04-20 | Bestätigt | Wolfe Research | Underperform |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-10-26 | Eingeleitet | Mizuho | Neutral |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-27 | Bestätigt | Credit Suisse | Outperform |
| 2022-01-27 | Bestätigt | Morgan Stanley | Overweight |
| 2022-01-27 | Bestätigt | Raymond James | Outperform |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-27 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | Eingeleitet | Redburn | Neutral |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Neutral |
| 2021-01-28 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-06-01 | Herabstufung | Goldman | Neutral → Sell |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Neutral |
| 2020-01-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-06-13 | Bestätigt | BofA/Merrill | Buy |
| 2019-02-07 | Bestätigt | BofA/Merrill | Buy |
| 2019-01-02 | Herabstufung | Citigroup | Neutral → Sell |
| 2018-11-30 | Hochstufung | Goldman | Neutral → Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-01-30 | Bestätigt | Citigroup | Neutral |
| 2018-01-25 | Bestätigt | Stifel | Buy |
| 2018-01-25 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2018-01-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-01-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-10-19 | Bestätigt | Stifel | Buy |
Alle ansehen
Abbott Laboratories Aktie (ABT) Neueste Nachrichten
Abbott opens new Kilkenny site for diabetes tech - SiliconRepublic.com
Mawer Investment Management Ltd. Sells 24,407 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Opens New Diabetes Care Mfg Facility in Ireland - MPO-mag
First Western Trust Bank Lowers Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott opens new FreeStyle Libre manufacturing plant in Ireland - Mass Device
MAI Capital Management Sells 9,904 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
US medtech firm Abbott creates 800 jobs in Kilkenny - Irish Independent
Abbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, Ireland - cnhinews.com
Vitamin D Testing Market Size to Reach USD 1774.70 Million by 2031 | SkyQuest Technology - Benzinga
Swiss National Bank Purchases 26,000 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
With 77% institutional ownership, Abbott Laboratories (NYSE:ABT) is a favorite amongst the big guns - Simply Wall St
Mizuho Securities USA LLC Has $12.86 Million Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Mutual of America Capital Management LLC Has $24.39 Million Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Mizuho Markets Americas LLC - MarketBeat
Abbott Laboratories (ABT): A Magnificent Dividend Growth Stock to Buy Now - Insider Monkey
Natixis Advisors LLC Purchases 204,478 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Kentucky Retirement Systems Insurance Trust Fund Sells 4,596 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Kentucky Retirement Systems Has $13.82 Million Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Ipswich Investment Management Co. Inc. Cuts Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Miramar Capital LLC - MarketBeat
Abbott extends executive agreements through 2026 By Investing.com - Investing.com Nigeria
Abbott Laboratories (ABT) Extends Executive Change in Control Ag - GuruFocus.com
Abbott Inks $8M Deal With Healthcare Fraudster In TM Suit - Law360
Abbott Laboratories stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Abbott Laboratories (NYSE:ABT) Stock Position Increased by First Long Island Investors LLC - MarketBeat
Abbott Laboratories (NYSE:ABT) Stock Holdings Increased by Simplify Asset Management Inc. - MarketBeat
Vectors Research Management LLC Makes New Investment in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Holdings Raised by CIBC Asset Management Inc - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Dearborn Partners LLC - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Curi RMB Capital LLC - MarketBeat
Victory Capital Management Inc. Trims Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Entropy Technologies LP Has $611,000 Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Drug Device Combination Market Is Booming Worldwide | 3M, Abbott Laboratories, AlloSource, Biomet Orthopedics Inc - openPR
Judge Finds Dexcom Infringed Abbott Patent That Hung Jury - Law360
Abbott Laboratories stock outperforms competitors despite losses on the day - MarketWatch
Abbott Gets Damages Trial as Judge Adds to DexCom's Patent Woes - Bloomberg Law
Topics: Missouri Margo Gill v. Abbott Laboratories, et al. - CVN News
ING Groep NV Grows Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Sivik Global Healthcare LLC Takes $6.84 Million Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Ferguson Wellman Capital Management Inc. - MarketBeat
Abbott Laboratories (NYSE:ABT) Stake Raised by KBC Group NV - MarketBeat
Versor Investments LP Acquires New Shares in Abbott Laboratories (NYSE:ABT) - MarketBeat
Los Angeles Capital Management LLC Sells 54,709 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Labs granted variances for fencing and buffer areas for new plant on north end of BG - BG Independent News
Abbott Laboratories stock underperforms Wednesday when compared to competitors - MarketWatch
Abbott Laboratories (NYSE:ABT) Shares Acquired by Schrum Private Wealth Management LLC - MarketBeat
Oppenheimer Asset Management Inc. Has $28.78 Million Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Saturna Capital Corp Cuts Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Stock Position Raised by Dillon & Associates Inc. - MarketBeat
Prime Capital Investment Advisors LLC Sells 26,308 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Invest with Confidence: Intrinsic Value Unveiled of Abbott Labor - GuruFocus.com
Finanzdaten der Abbott Laboratories-Aktie (ABT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.17%
3.98%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):